|
Multiple sclerosis
Citations 191-200 of 475 total displayed.
|
Past content
(since Jan 2001):
|
- ARTICLES
Quantifying the risks and benefits of natalizumab in relapsing multiple sclerosis
- E. R. Dorsey, J. P. Thompson, K. Noyes, A. W. Dick, R. G. Holloway, and S. R. Schwid
Neurology 2007; 68: 1524-1528.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Natalizumab reduces visual loss in patients with relapsing multiple sclerosis
- L. J. Balcer, S. L. Galetta, P. A. Calabresi, C. Confavreux, G. Giovannoni, E. Havrdova, M. Hutchinson, L. Kappos, F. D. Lublin, D. H. Miller, P. W. O'Connor, J. T. Phillips, C. H. Polman, E. -W. Radue, R. A. Rudick, W. H. Stuart, A. Wajgt, B. Weinstock-Guttman, D. R. Wynn, F. Lynn, M. A. Panzara for the AFFIRM and SENTINEL Investigators
Neurology 2007; 68: 1299-1304.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Steroid-responsive neurologic relapses in a child with a proteolipid protein-1 mutation
- M. P. Gorman, M. R. Golomb, L. E. Walsh, G. M. Hobson, J. Y. Garbern, R. P. Kinkel, B. T. Darras, D. K. Urion, and Y. Z. Eksioglu
Neurology 2007; 68: 1305-1307.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Randomized, double-blind, dose-comparison study of glatiramer acetate in relapsing–remitting MS
- J. A. Cohen, M. Rovaris, A. D. Goodman, D. Ladkani, D. Wynn, M. Filippi for the 9006 Study Group
Neurology 2007; 68: 939-944.
[Abstract]
[Full text]
[PDF]
- CLINICAL/SCIENTIFIC NOTES
Multiple sclerosis: Relating MxA transcription to anti-interferon-ß-neutralizing antibodies
- L. A. Hoffmann, M. Krumbholz, H. Faber, T. Kuempfel, M. Starck, W. Pöllmann, E. Meinl, and R. Hohlfeld
Neurology 2007; 68: 958-959.
[Full text]
[PDF]
- ARTICLE
High CSF neurofilament heavy chain levels in neuromyelitis optica
- I. Miyazawa, I. Nakashima, A. Petzold, K. Fujihara, S. Sato, and Y. Itoyama
Neurology 2007; 68: 865-867.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Age at onset determines the occurrence of the progressive phase of multiple sclerosis
- B. Stankoff, S. Mrejen, A. Tourbah, B. Fontaine, O. Lyon-Caen, C. Lubetzki, and M. Rosenheim
Neurology 2007; 68: 779-781.
[Abstract]
[Full text]
[PDF]
- ARTICLES
APOE  4 is associated with impaired verbal learning in patients with MS
- G. Koutsis, M. Panas, E. Giogkaraki, C. Potagas, G. Karadima, C. Sfagos, and D. Vassilopoulos
Neurology 2007; 68: 546-549.
[Abstract]
[Full text]
[PDF]
- EDITORIALS
Does benign multiple sclerosis today imply benign multiple sclerosis tomorrow?: Implications for treatment
- Sean J. Pittock
Neurology 2007; 68: 480-481.
[Full text]
[PDF]
- ARTICLES
Longitudinal follow-up of "benign" multiple sclerosis at 20 years
- Ana-Luiza Sayao, Virginia Devonshire, and Helen Tremlett
Neurology 2007; 68: 496-500.
[Abstract]
[Full text]
[PDF]
|
|
